Director/PDMR Shareholding

Summary by AI BETAClose X

Executive directors Christopher O’Shea and Russell O’Brien acquired shares under Centrica’s Share Incentive Plan on 10 November 2026: O’Shea received 97 Partnership shares at £1.54095 and 22 Matching shares at £1.52516666 (119 shares aggregated at £1.538 per share, total £183.03); O’Brien received 98 Partnership shares at £1.54095 and 22 Matching shares at £1.52516666 (120 shares aggregated at £1.538 per share, total £184.57). Partnership shares were purchased on the London Stock Exchange and Matching shares were acquired outside a trading venue, representing small executive purchases with immaterial cash value relative to market capitalization.

Disclaimer*

Companies

Centrica (CNA)
UK 100

Latest directors dealings